| Bioactivity | GLP-1(32-36)amide, a pentapeptide, derived from the C terminus of the glucoregulatory hormone GLP-1. GLP-1(32-36)amide could inhibit weight gain and modulate whole body glucose metabolism in diabetic mice[1][2]. | ||||||
| Invitro | GLP-1(32-36)amide (0.1-10 μM; 24 h) retains cell viability and decreases apoptosis against Streptozotocin (STZ; 1 μM) in INS‐1 cells[2]. Cell Viability Assay[2] Cell Line: | ||||||
| Name | GLP-1(32-36)amide | ||||||
| CAS | 1417302-71-6 | ||||||
| Sequence | Leu-Val-Lys-Gly-Arg-NH2 | ||||||
| Shortening | LVKGR-NH2 | ||||||
| Formula | C25H50N10O5 | ||||||
| Molar Mass | 570.73 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
GLP-1(32-36)amide
CAS: 1417302-71-6 F: C25H50N10O5 W: 570.73
GLP-1(32-36)amide, a pentapeptide, derived from the C terminus of the glucoregulatory hormone GLP-1. GLP-1(32-36)amide c
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.